BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37973241)

  • 1. Interpretation of Prostate Magnetic Resonance Imaging Using Prostate Imaging and Data Reporting System Version 2.1: A Primer.
    Spilseth B; Margolis DJA; Gupta RT; Chang SD
    Radiol Clin North Am; 2024 Jan; 62(1):17-36. PubMed ID: 37973241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer.
    Chu CE; Cowan JE; Lonergan PE; Washington SL; Fasulo V; de la Calle CM; Shinohara K; Westphalen AC; Carroll PR
    Eur Urol Oncol; 2022 Oct; 5(5):537-543. PubMed ID: 33483265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can high b-value 3.0 T biparametric MRI with the Simplified Prostate Image Reporting and Data System (S-PI-RADS) be used in biopsy-naïve men?
    Wang G; Yu G; Chen J; Yang G; Xu H; Chen Z; Wang G; Bai Z
    Clin Imaging; 2022 Aug; 88():80-86. PubMed ID: 34243992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?
    Hoffmann R; Logan C; O'Callaghan M; Gormly K; Chan K; Foreman D
    Int Urol Nephrol; 2018 Jan; 50(1):13-19. PubMed ID: 29188489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging of the prostate: interpretation using the PI-RADS V2.
    Torregrosa Andrés A; Otero García M; Sineiro Galiñanes M
    Radiologia; 2017; 59(2):128-138. PubMed ID: 28012730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interobserver Agreement and Accuracy in Interpreting mpMRI of the Prostate: a Systematic Review.
    Annamalai A; Fustok JN; Beltran-Perez J; Rashad AT; Krane LS; Triche BL
    Curr Urol Rep; 2022 Jan; 23(1):1-10. PubMed ID: 35226257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of PI-RADS version 2 and PI-RADS version 2.1 for the detection of transition zone prostate cancer.
    Tamada T; Kido A; Takeuchi M; Yamamoto A; Miyaji Y; Kanomata N; Sone T
    Eur J Radiol; 2019 Dec; 121():108704. PubMed ID: 31669798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions.
    Padhani AR; Weinreb J; Rosenkrantz AB; Villeirs G; Turkbey B; Barentsz J
    Eur Urol; 2019 Mar; 75(3):385-396. PubMed ID: 29908876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Prostate Imaging-Reporting and Data System (PI-RADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio Study.
    Ahdoot M; Lebastchi AH; Long L; Wilbur AR; Gomella PT; Mehralivand S; Daneshvar MA; Yerram NK; O'Connor LP; Wang AZ; Gurram S; Bloom J; Siddiqui MM; Linehan WM; Merino M; Choyke PL; Pinsky P; Parnes H; Shih JH; Turkbey B; Wood BJ; Pinto PA;
    Eur Urol Oncol; 2022 Apr; 5(2):176-186. PubMed ID: 33846112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI-RADS Version 2: A Pictorial Update.
    Purysko AS; Rosenkrantz AB; Barentsz JO; Weinreb JC; Macura KJ
    Radiographics; 2016; 36(5):1354-72. PubMed ID: 27471952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of use of Prostate Imaging Reporting and Data System Version 2 (PI-RADS V2) with multiparametric MR imaging for the detection of prostate cancer.
    Zhang L; Tang M; Chen S; Lei X; Zhang X; Huan Y
    Eur Radiol; 2017 Dec; 27(12):5204-5214. PubMed ID: 28656462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2.
    Turkbey B; Rosenkrantz AB; Haider MA; Padhani AR; Villeirs G; Macura KJ; Tempany CM; Choyke PL; Cornud F; Margolis DJ; Thoeny HC; Verma S; Barentsz J; Weinreb JC
    Eur Urol; 2019 Sep; 76(3):340-351. PubMed ID: 30898406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.
    Faiena I; Salmasi A; Mendhiratta N; Markovic D; Ahuja P; Hsu W; Elashoff DA; Raman SS; Reiter RE
    J Urol; 2019 Jan; 201(1):91-97. PubMed ID: 30577397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate MRI evolution in clinical practice: Audit of tumour detection and staging versus prostatectomy with staged introduction of multiparametric MRI and Prostate Imaging Reporting and Data System v2 reporting.
    Raeside M; Low A; Cohen P; Sutherland P; Gormly K
    J Med Imaging Radiat Oncol; 2019 Aug; 63(4):487-494. PubMed ID: 30951248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy and Variability of Prostate Multiparametric Magnetic Resonance Imaging Interpretation Using the Prostate Imaging Reporting and Data System: A Blinded Comparison of Radiologists.
    Pickersgill NA; Vetter JM; Andriole GL; Shetty AS; Fowler KJ; Mintz AJ; Siegel CL; Kim EH
    Eur Urol Focus; 2020 Mar; 6(2):267-272. PubMed ID: 30327280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-Bore 3-T MR-guided Transrectal Targeted Prostate Biopsy: Prostate Imaging Reporting and Data System Version 2-based Diagnostic Performance for Detection of Prostate Cancer.
    Tan N; Lin WC; Khoshnoodi P; Asvadi NH; Yoshida J; Margolis DJ; Lu DS; Wu H; Sung KH; Lu DY; Huang J; Raman SS
    Radiology; 2017 Apr; 283(1):130-139. PubMed ID: 27861110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis.
    Hamoen EHJ; de Rooij M; Witjes JA; Barentsz JO; Rovers MM
    Eur Urol; 2015 Jun; 67(6):1112-1121. PubMed ID: 25466942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric MR imaging of the Prostate: Interpretation Including Prostate Imaging Reporting and Data System Version 2.
    Furlan A; Borhani AA; Westphalen AC
    Radiol Clin North Am; 2018 Mar; 56(2):223-238. PubMed ID: 29420978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of Prostate Imaging Reporting and Data System Version 2 for the Detection of Prostate Cancer.
    Hofbauer SL; Maxeiner A; Kittner B; Heckmann R; Reimann M; Wiemer L; Asbach P; Haas M; Penzkofer T; Stephan C; Friedersdorff F; Fuller F; Miller K; Cash H
    J Urol; 2018 Oct; 200(4):767-773. PubMed ID: 29733838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficiency of multiparametric magnetic resonance imaging (mpMRI) using PI-RADS Version 2 in the diagnosis of clinically significant prostate cancer.
    Zhao C; Gao G; Fang D; Li F; Yang X; Wang H; He Q; Wang X
    Clin Imaging; 2016; 40(5):885-8. PubMed ID: 27179959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.